- Home
- ECO vs OPK Comparison
ECO vs OPK Comparison
Compare ECO & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECO
- OPK
- Stock Information
- Founded
- ECO 2018
- OPK 2007
- Country
- ECO Greece
- OPK United States
- Employees
- ECO N/A
- OPK N/A
- Industry
- ECO
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- ECO
- OPK Health Care
- Exchange
- ECO Nasdaq
- OPK Nasdaq
- Market Cap
- ECO 699.6M
- OPK 1.1B
- IPO Year
- ECO N/A
- OPK 1995
- Fundamental
- Price
- ECO $23.07
- OPK $1.34
- Analyst Decision
- ECO Strong Buy
- OPK Buy
- Analyst Count
- ECO 1
- OPK 4
- Target Price
- ECO $40.00
- OPK $2.75
- AVG Volume (30 Days)
- ECO 138.9K
- OPK 3.3M
- Earning Date
- ECO 08-08-2025
- OPK 08-06-2025
- Dividend Yield
- ECO 9.59%
- OPK N/A
- EPS Growth
- ECO N/A
- OPK N/A
- EPS
- ECO 2.48
- OPK N/A
- Revenue
- ECO $362,254,143.00
- OPK $689,408,000.00
- Revenue This Year
- ECO N/A
- OPK N/A
- Revenue Next Year
- ECO $3.94
- OPK $6.98
- P/E Ratio
- ECO $9.33
- OPK N/A
- Revenue Growth
- ECO N/A
- OPK N/A
- 52 Week Low
- ECO $17.91
- OPK $1.21
- 52 Week High
- ECO $35.64
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- ECO 50.22
- OPK 51.42
- Support Level
- ECO $22.73
- OPK $1.32
- Resistance Level
- ECO $24.02
- OPK $1.36
- Average True Range (ATR)
- ECO 0.53
- OPK 0.04
- MACD
- ECO 0.08
- OPK 0.00
- Stochastic Oscillator
- ECO 59.02
- OPK 65.38
About ECO Okeanis Eco Tankers Corp.
Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers and eight VLCC tankers.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.